TRG-192

Overview

TRG-192 is a potent and selective glutaminase ( GLS ) inhibitor with an IC 50 of 68 nM. TRG-192 inhibits intracellular glutamate levels. TRG-192 is applicable to related research on non-small cell lung cancer .

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Lung Cancer | Products > Disease Areas > Respiratory Cancer | Products > Disease Areas > Non-Small Cell Lung Cancer | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Signaling Pathways > Glutaminase

Product Information

• Catalog No.: HY-181890
• CAS No.: 3080792-24-8
• Molecular Formula: C24H20F6N8O2S2
• Molecular Weight: 630.59
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source